Virios Therapeutics
Stock Forecast, Prediction & Price Target
Virios Therapeutics Financial Estimates
Virios Therapeutics Revenue Estimates
Virios Therapeutics EBITDA Estimates
Virios Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $29.82M Low: $29.82M High: $29.82M avg. 0% | Avg: $128.77M Low: $128.77M High: $128.77M avg. 331.70% | Avg: $18.73M Low: $18.73M High: $18.73M avg. -85.45% | Avg: $36.88M Low: $36.88M High: $36.88M avg. 96.90% |
Net Income
% change YoY
| $-15.96M N/A | $-12.18M 23.68% | $-5.29M 56.52% | Avg: $-6.96M Low: $-3.94M High: $-3.00M avg. -31.47% | Avg: $-11.20M Low: $-6.57M High: $-2.81M avg. -60.96% | Avg: $-4.69M Low: $-4.69M High: $-4.69M avg. 58.11% | Avg: $-4.31M Low: $-4.31M High: $-4.31M avg. 8.00% |
EBITDA
% change YoY
| $-15.64M N/A | $-12.31M 21.26% | $150.90K 101.22% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.92 N/A | -$1.1 42.70% | -$0.28 74.54% | Avg: -$0.19 Low: -$0.21 High: -$0.16 avg. 33.33% | Avg: -$0.28 Low: -$0.35 High: -$0.15 avg. -49.99% | Avg: -$0.25 Low: -$0.25 High: -$0.25 avg. 10.71% | Avg: -$0.23 Low: -$0.23 High: -$0.23 avg. 7.99% |
Operating Expenses
% change YoY
| $15.64M N/A | $12.31M -21.26% | $5.44M -55.77% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Virios Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -6.58% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -3.94M, average is -6.96M and high is -3.00M.
What is Virios Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 85.79% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $29.82M, average is $29.82M and high is $29.82M.
What is Virios Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 0.51% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.21, average is -$0.19 and high is $-0.16.